# Quality-Control Self-Audit — Wave 0

**Date:** 10 July 2026  
**Scope:** Foundation Wave only. “Partial” or “Fail/Open” does not mean the complete program failed; it identifies work intentionally left for later waves.

| Test | Status | Wave 0 finding | Required action |
|---|---|---|---|
| Source coverage | PARTIAL | Current site and several global official standards/technology sources captured; Israeli market/regulatory coverage not yet complete | Wave 1 primary-source expansion |
| Primary-source ratio | PARTIAL | Strong for Google, WordPress, WooCommerce, WHO, NIST, W3C, NLM/WHO licenses; competitor seed includes secondary discovery | Replace discovery sources with official competitor and Israeli primary sources |
| Citation validity | PASS for used findings | Claims in foundation files resolve to source-ledger records/URLs | Archive/capture all later sources |
| Broken links | PARTIAL | Some public pages were link-discovered but not fetched; full automated check unavailable | Owner crawl plus broken-link checker |
| Unsupported numbers | PASS | No market size, keyword metric, ranking, conversion or revenue invented | Maintain numeric record rule |
| Stale data | PARTIAL | Access date recorded; source publication dates vary | Add expiry/update cadence and current official verification |
| Hebrew keyword preservation | PASS | 207 seed queries preserve the required Hebrew phrases; English/transliteration fields are included where useful | Native-speaker QA, demand expansion and variant review in Wave 3 |
| Invented Semrush/Search Console metrics | PASS | All such fields marked DATA REQUIRED | Fill only from authenticated exports |
| Competitor-copy risk | PASS | Archetypes summarized; no competitor prose used as content | Continue coverage matrices, not rewriting |
| Medical-evidence gaps | FAIL/OPEN | No specialty evidence packs completed | Wave 4 and page-level review |
| Privacy/regulatory assumptions | PASS as checklist | No unsupported legal conclusion presented | Qualified Israeli review in Wave 1/5/6/7 |
| Keyword cannibalization | OPEN | Seed canonical hypotheses only | Localized SERP overlap + GSC/current URL data |
| Unsupported page proliferation | PASS | All new URL candidates provisional and gated | Enforce P0–P7 page gates |
| Monetization conflicts | PARTIAL | Separation principles defined; contracts/ranking policy absent | Wave 5/8 operating policy |
| Missing account/back-office journeys | OPEN | Not specified in detail | Waves 5–7 |
| Missing implementation dependencies | PASS at program level | Wave dependencies and data blockers documented | Add feature-level dependencies later |
| Unranked recommendations | PARTIAL | Strategic priorities ranked; detailed feature portfolio pending | Score in each later wave |
| Israeli lawyer required areas | OPEN/FLAGGED | Privacy, advertising, pharmacy, devices, ecommerce, finance, reviews, children, transfers | Retain qualified counsel |
| Clinician/pharmacist/device expert required areas | OPEN/FLAGGED | Medical claims, drugs, devices, diagnostics, aesthetics, surgery, fertility, longevity | Establish reviewer panel |
| Security professional required areas | OPEN/FLAGGED | Live stack and data flows not audited | Threat model, code/config review, testing |
| Accountant required areas | OPEN/FLAGGED | No financial actuals/model | Wave 8 |
| Existing URL preservation | PASS | No deletion or redirect recommended | Maintain freeze until evidence |
| Research continuation integrity | PASS | Machine-readable ledger and nine copy-ready continuation prompts created | Update after every wave |

## Wave 0 completion statement

Wave 0 is complete as a research control plane and starting-state pack. No required workstream is claimed complete in full. The national-scale commission remains active through Waves 1–9.

## Known limitations

- no authenticated Google Israel SERP environment;
- no Search Console, analytics, backlink, crawl, CMS, CRM, provider, supplier or financial data;
- limited fetchability of some Israeli government and site pages during this run;
- no interviews;
- no qualified Israeli legal opinion;
- no page-level clinical evidence review;
- no code, security, accessibility or performance audit;
- no provider or product verification;
- no market-size or unit-economics evidence.

## QA rule for later waves

A later deliverable must not be marked complete merely because a narrative exists. Completion requires its structured tables, source ledger, limitations, unresolved data fields, owner decisions, risk updates, and pass/fail audit.

## Wave 0 dataset counts

| Dataset | Rows/items | QA note |
|---|---:|---|
| `02_SOURCE_LEDGER.csv` | 48 | Includes accessed, queued and owner-data sources; queued/owner records are not treated as verified evidence. |
| `03_COMPETITOR_MASTER.csv` | 38 | Seed universe; current scale/pricing/capability details remain subject to official Wave 2 audit. |
| `05_GLOBAL_CAPABILITY_MATRIX.csv` | 10 | Archetype-level, not page-level evidence. |
| `06_KEYWORD_UNIVERSE.csv` | 207 | All commercial/search metrics marked `DATA REQUIRED`. |
| `07_KEYWORD_TO_URL_MAP.csv` | 150 | Provisional preservation-first canonical hypotheses. |
| `28_RISK_REGISTER.csv` | 47 | Preliminary qualitative ratings; quantitative risk scoring pending. |
